SCHEMBL628652

SCHEMBL628652

CC(C)CCCCC(=O)OCC(COC(=O)CCCCC(C)C)OC(=O)CCCCC(C)C

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.67
LMNA P02545 1/20 0.67
PRKCA P17252 3/20 0.57
PRKCE Q02156 2/20 0.57
PRKCQ Q04759 2/20 0.57
PRKCD Q05655 2/20 0.57
LPAR3 Q9UBY5 7/20 0.54
LPAR1 Q92633 4/20 0.54
ENPP2 Q13822 3/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
LPAR2 Q9HBW0 2/20 0.52
CYP3A4 P08684 1/20 0.49
TSHR P16473 1/20 0.49
ATM Q13315 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
TLR2 O60603 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL152023 0.98 ALDH1A1 (0.70) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL6061699 0.98 ALDH1A1 (0.70) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL6365316 0.98 ALDH1A1 (0.70) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL964615 0.95 ALDH1A1 (0.64) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL26715725 0.94 ALDH1A1 (0.69) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL30555799 0.92 ALDH1A1 (0.82) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL28151776 0.92 ALDH1A1 (0.82) ALDH1A1LMNAPRKCAPRKCEPRKCQ
Tricaprilin SCHEMBL28287799 0.92 ALDH1A1 (0.82) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL30555861 0.92 ALDH1A1 (0.82) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL5155403 0.90 PRKCA (0.72) ALDH1A1LMNAPRKCAPRKCEPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024237182-A1 TOPICAL COMPOSITION アピ株式会社 2024-11-21 WO claimed
WO-2024237181-A1 TOPICAL COMPOSITION アピ株式会社 2024-11-21 WO claimed
CN-115666632-A Malaria transmission blocking vaccine 帕斯公司 2023-01-31 CN claimed
CN-115531228-A Cosmetic composition for improving hair containing no siloxane UCL株式会社 2022-12-30 CN claimed
US-8183232-B2 Therapeutic agent for hemorrhoidal disease TEIKOKU SEIYAKU CO., LTD. (JP) 2012-05-22 US claimed
US-6268355-B1 TRANSDERMAL ASPIRIN TEIKOKU SEIYAKU CO., LTD. (JP) 2001-07-31 US claimed
EP-0920869-A1 STABLE ASPIRIN-CONTAINING PREPARATIONS FOR EXTERNAL USE TEIKOKU SEIYAKU CO., LTD. (JP) 1999-06-09 EP claimed
JP-57165305-A None JP disclosed
JP-11199476-A None JP disclosed
JP-11246329-A None JP disclosed
US-12589061-B2 Method for producing silica particles and their use in cosmetic compositions MOMENTIVE PERFORMANCE MATERIALS JAPAN LLC (JP) 2026-03-31 US disclosed
US-20260060903-A1 BIODEGRADABLE SPHERICAL PARTICLES FOR COSMETIC APPLICATIONS MOMENTIVE PERFORMANCE MAT INC (US) 2026-03-05 US disclosed
US-20250354008-A1 BIO-DERIVED GREEN PARTICLE COMPOSITIONS AND METHODS THEREOF MOMENTIVE PERFORMANCE MAT INC (US) 2025-11-20 US disclosed
EP-0687721-A2 Detergent composition Ajinomoto Co., Inc. (JP) 1995-12-20 EP disclosed
EP-0671157-A1 Cosmetic composition comprising cationic thickener OSAKA YUKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1995-09-13 EP disclosed
EP-0459705-B1 Surface-active Organopolysiloxanes SHINETSU CHEMICAL CO (JP) 1994-06-01 EP disclosed
US-5104998-A ORGANOPOLYSILOXANE MODIFIED WITH POLYETHER AND HIGHER APLIPHATIC ETHER SHIN-ETSU CHEMICAL CO., LTD. (JP) 1992-04-14 US disclosed
EP-0459705-A2 Surface-active Organopolysiloxanes Shin-Etsu Chemical Co., Ltd. (JP) 1991-12-04 EP disclosed
US-4497847-A MONO AND DIESTERS OF GLYCEROL AND SATURATED CARBOXYLIC ACIDS AS PLASTICIZERS SANKYO COMPANY, LIMITED (JP) 1985-02-05 US disclosed
JP-S57165305-A METHOD OF INCREASING THE POTENCY OF BACTERICIDAL DISINFECTANT OF SURFACE ACTIVE AGENT MARUISHI SEIYAKU KK 1982-10-12 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589061-B2 Method for producing silica particles and their use in cosmetic compositions RAD50, XRCC5, DPY30 ALDH1A1 4048/4885LMNA 2166/4885PRKCA 2776/4885
US-20260060903-A1 BIODEGRADABLE SPHERICAL PARTICLES FOR COSMETIC APPLICATIONS DPM1, DNER, SAMM50 ALDH1A1 2439/4885LMNA 339/4885PRKCA 3165/4885
US-20250354008-A1 BIO-DERIVED GREEN PARTICLE COMPOSITIONS AND METHODS THEREOF ALG1, PARG, RECQL ALDH1A1 2799/4885LMNA 2233/4885PRKCA 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.